Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
11,879
datasets available to search
ShareScore release 0.9.0
Dataset results
11,879 results for “participation”
An Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT02783300. IPD Sharing: YES. Countries: 4. Publications: 0.
Safety and Pharmacokinetics of Alpha-1 MP (Alpha1-proteinase Inhibitor (Human), Modified Process) in Participants With Alpha1-Antitrypsin Deficiency
ClinicalTrials.gov study NCT02870309. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
ClinicalTrials.gov study NCT01613599. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Investigational Immunotherapy Study of BMS-986258 Alone and in Combination With Nivolumab in Participants With Solid Cancers That Are Advanced or Have Spread
ClinicalTrials.gov study NCT03446040. IPD Sharing: Not stated. Countries: 4. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease
ClinicalTrials.gov study NCT04777331. IPD Sharing: YES. Countries: 9. Publications: 0.
A Study of Atezolizumab in Combination With Either Obinutuzumab Plus Bendamustine or Obinutuzumab Plus (+) Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Participants With Follic
ClinicalTrials.gov study NCT02596971. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Impact of Natalizumab Versus Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants
ClinicalTrials.gov study NCT02342704. IPD Sharing: Not stated. Countries: 9. Publications: 1.
A Study of LY3451838 in Healthy Participants
ClinicalTrials.gov study NCT03692949. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema
ClinicalTrials.gov study NCT02699450. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
ClinicalTrials.gov study NCT03980483. IPD Sharing: YES. Countries: 10. Publications: 1.
Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Participants
ClinicalTrials.gov study NCT00622505. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair)
ClinicalTrials.gov study NCT01922037. IPD Sharing: Not stated. Countries: 1. Publications: 10.
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)
ClinicalTrials.gov study NCT03556202. IPD Sharing: YES. Countries: 19. Publications: 1.
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 (Crinecerfont) in Pediatric Participants With Congenital Adrenal Hyperplasia
ClinicalTrials.gov study NCT04045145. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT05048719. IPD Sharing: YES. Countries: 5. Publications: 2.
A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graf
ClinicalTrials.gov study NCT02336230. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Postprandial Hyperglycemia in Participants With Type 2 Diabetes
ClinicalTrials.gov study NCT01159938. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections
ClinicalTrials.gov study NCT00711802. IPD Sharing: YES. Countries: 3. Publications: 1.
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities
ClinicalTrials.gov study NCT05822830. IPD Sharing: YES. Countries: 2. Publications: 2.
A Study of Venetoclax in Combination With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03567616. IPD Sharing: YES. Countries: 3. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.